Faculty

Andy Stergachis

Adjunct Professor, Epidemiology
Professor, Pharmacy
Professor, Global Health
Adjunct Professor, Health Metrics Sciences

206-221-0703

Education

PhD Pharmacy, University of Minnesota, 1979
MS Pharmacy, University of Minnesota, 1976
BPharm Pharmacy, Washington State University, 1975

Contact

206-221-0703

Office H-362B, Health Sciences Building
Box 357631
WA

Research Areas

Research Interests

Dr. Stergachis' research focus is pharmacoepidemiology, global drugs and vaccine safety, pharmaceutical outcomes research, and public health systems research. He directed a pharmacovigilance pregnancy registry study on the safety of first trimester antimalarials conducted in three sub-Saharan African countries. He is one of very few pharmacists ever elected to the National Academy of Medicine. His research has been supported, in part, by the Bill and Melinda Gates Foundation, USAID, the Barr Foundation, the Partnership for Quality Medical Donations, and USP. He is a Fellow of the International Society for Pharmacoepidemiology, Chair of the Expert Panel to Review Surveillance and Screening Technologies for the Quality Assurance of Medicines for United States Pharmacopeia, Chair of the Low-dose Primaquine Safety Study Group for the WorldWide Antimalarial Resistance Network and member of the Access and Product Management Advisory Committee for Medicines for Malaria Venture. He has conducted pharmacovigilance trainings and related pharmaceutical systems strengthening activities in numerous low- and middle-income countries (e.g., Namibia, Vietnam, Rwanda, Ethiopia, Zimbabwe, China, India, Kenya, Bangladesh, Eritrea, Philippines, Uganda, and Ukraine). Through his affiliation with the Northwest Center for Public Health Practice, he also works on workforce development and research in emergency preparedness with the public health community.

Recent Publications (PubMed)

Online delivery of oral HIV pre- and post-exposure prophylaxis: findings from the ePrEP Kenya pilot.
(2025 Jun)
J Int AIDS Soc 28 Suppl 1(): e26468
Kiptinness C, Naik P, Kareithi T, Thuo N, Okello P, Culquichicon C, Rafferty M, Abdulrashid S, Jomo E, Nyamasyo N, Wood T, Mendonca R, Malen RC, Dettinger JC, Pintye J, Mwangi J, Stergachis A, Onentia J, Curran K, Mugambi ML, Were D, Ngure K, Sharma M, Ortblad KF, ePrEP Kenya team
Pharmacovigilance processes in low- and middle-income countries: moving from data collection to data analysis and interpretation.
(2025)
Ther Adv Drug Saf 16(): 20420986241300006
Menang O, van Eeuwijk P, Maigetter K, Stergachis A, Burri C
Willingness to pay for HIV pre- and post-exposure prophylaxis services delivered via an online pharmacy in Kenya.
(2025 Apr 22)
BMC Health Serv Res 25(1): 576
Montaño MA, Chen Y, Saldarriaga EM, Thuo N, Kiptinness C, Stergachis A, Mugambi ML, Ngure K, Ortblad KF, Sharma M
Safety, immunogenicity, and effectiveness of chikungunya vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis.
(2025 Apr 18)
Reprod Health 22(1): 56
Berrueta M, Ciapponi A, Mazzoni A, Ballivian J, Bardach A, Sambade JM, Brizuela M, Stegelman K, Comandé D, Parker EPK, Stergachis A, Xiong X, Munoz FM, Buekens PM
Safety, immunogenicity, efficacy, and effectiveness of Lassa fever vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis.
(2025 Apr 15)
Reprod Health 22(1): 53
Ballivian J, Berrueta M, Ciapponi A, Sambade JM, Stegelmann K, Mazzoni A, Bardach A, Brizuela M, Comandé D, Castellana N, Parker EPK, Stergachis A, Xiong X, Munoz FM, Buekens PM
Show complete publication list